Section 21 Application Submission

Applicants may submit any application for review through the new Covid19 submission platform – not only Covid 19 related products may be submitted.

The portal access is linked to your license number (for companies).  There are one of three emails you can use to get more information and to request access to the portal – backlog@sahpra.co.za, newmedicines@sahpra.co.za or variations@sahpra.co.za.  They will provide you with all the necessary guidance